Rating On Watch: Analysts at Barclays Capital Maintained their Overweight rating for Exova Group Plc (LON:EXO) with GBX 220.00 Target Price per Share

November 25, 2016 - By Louis Casey

Exova Group Plc (LON:EXO) Rating

In an analyst report issued to clients on Friday, 25 November, Exova Group Plc (LON:EXO) stock had its Overweight Rating reiterated by expert analysts at Barclays Capital. They currently have a GBX 220.00 target on firm. Barclays Capital’s target indicates a potential upside of 13.11% from the company’s current stock price.

Exova Group Plc (LON:EXO) Ratings Coverage

Out of 6 analysts covering Exova Group Plc (LON:EXO), 6 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. GBX 240 is the highest target while GBX 158 is the lowest. The GBX 216 average target is 9.51% above today’s (GBX 197.25) stock price. Exova Group Plc has been the topic of 27 analyst reports since August 24, 2015 according to StockzIntelligence Inc. The stock of Exova Group Plc (LON:EXO) earned “Outperform” rating by Credit Suisse on Wednesday, November 11. Barclays Capital maintained Exova Group Plc (LON:EXO) on Monday, September 14 with “Overweight” rating. Investec maintained the shares of EXO in a report on Wednesday, November 11 with “Buy” rating. The firm has “Buy” rating given on Thursday, March 3 by Shore Capital. The stock of Exova Group Plc (LON:EXO) earned “Buy” rating by Goldman Sachs on Thursday, September 1. Shore Capital maintained the stock with “Buy” rating in Wednesday, August 31 report. As per Tuesday, February 23, the company rating was maintained by Shore Capital. The rating was initiated by Shore Capital with “Buy” on Friday, January 8. The company was maintained on Friday, March 4 by Barclays Capital. The stock has “Buy” rating given by Shore Capital on Thursday, September 22.

It is down 23.28% since April 27, 2016 and is uptrending. It has outperformed by 17.87% the S&P500.

Exova Group plc is a United Kingdom well-known provider of testing and advisory services. The company has a market cap of 493.98 million GBP. The Firm is a laboratory testing firm operating approximately 140 laboratories and offices in over 30 countries throughout Europe, the Americas, the Middle East and Asia/Asia Pacific. It has a 24.17 P/E ratio. The Company’s divisions include Europe, Americas and Rest of World.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>